Form 4: Guardant Health's Co-CEO Helmy Eltoukhy Reports Stock Transactions
SEC Form 4 Filing
Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.
Summary
- On March 31, 2024, Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- Eltoukhy vested 11,461 shares of common stock from restricted stock units.
- 4,509 shares were withheld by the company to cover tax obligations related to the vesting of the restricted stock units at a price of $20.63.
- Following these transactions, Eltoukhy directly owns 2,092,961 shares of Guardant Health common stock and 34,385 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the executive's stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of stock transactions and vesting of restricted stock units. |
| 03/31/2024 | First vesting date of restricted stock units. |
| 06/30/2024 | Second vesting date of restricted stock units. |
| 09/30/2024 | Third vesting date of restricted stock units. |
| 12/31/2024 | Fourth vesting date of restricted stock units. |
| 04/01/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.